Suppr超能文献

脂质体在药物开发中的应用——关注胃肠病学靶点。

Application of liposomes in drug development--focus on gastroenterological targets.

机构信息

Department of General Surgery, the Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, People's Republic of China.

出版信息

Int J Nanomedicine. 2013;8:1325-34. doi: 10.2147/IJN.S42153. Epub 2013 Apr 8.

Abstract

Over the past decade, liposomes became a focal point in developing drug delivery systems. New liposomes, with novel lipid molecules or conjugates, and new formulations opened possibilities for safely and efficiently treating many diseases including cancers. New types of liposomes can prolong circulation time or specifically deliver drugs to therapeutic targets. This article concentrates on current developments in liposome based drug delivery systems for treating diseases of the gastrointestinal tract. We will review different types and uses of liposomes in the development of therapeutics for gastrointestinal diseases including inflammatory bowel diseases and colorectal cancer.

摘要

在过去的十年中,脂质体成为了开发药物输送系统的焦点。新型脂质体,采用新型脂质分子或缀合物,以及新的制剂,为安全有效地治疗包括癌症在内的许多疾病提供了可能。新型脂质体可以延长循环时间或专门将药物递送到治疗靶点。本文集中讨论了基于脂质体的药物输送系统在治疗胃肠道疾病方面的最新进展。我们将回顾不同类型和用途的脂质体在治疗胃肠道疾病(包括炎症性肠病和结直肠癌)的治疗药物开发中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f19/3623572/bd9b9e1e265f/ijn-8-1325Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验